BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 21801234)

  • 1. Chronic lymphocytic leukemia with nuclear budding.
    Huang JZ; Folbe MH; Richards SK; Kolins MD
    Eur J Haematol; 2012 Jan; 88(1):92. PubMed ID: 21801234
    [No Abstract]   [Full Text] [Related]  

  • 2. Richter's transformation of chronic lymphocytic leukemia.
    Giardino AA; O'Regan K; Jagannathan JP; Elco C; Ramaiya N; Lacasce A
    J Clin Oncol; 2011 Apr; 29(10):e274-6. PubMed ID: 21220587
    [No Abstract]   [Full Text] [Related]  

  • 3. Agranulocytosis occurring in a patient with chronic lymphocytic leukemia in complete remission; treatment by rituximab and cyclosporin.
    Costello RT; Sébahoun G
    Leuk Res; 2010 Dec; 34(12):e329-30. PubMed ID: 20723978
    [No Abstract]   [Full Text] [Related]  

  • 4. Obinutuzumab as frontline treatment of chronic lymphocytic leukemia: updated results of the CLL11 study.
    Goede V; Fischer K; Engelke A; Schlag R; Lepretre S; Montero LF; Montillo M; Fegan C; Asikanius E; Humphrey K; Fingerle-Rowson G; Hallek M
    Leukemia; 2015 Jul; 29(7):1602-4. PubMed ID: 25634683
    [No Abstract]   [Full Text] [Related]  

  • 5. Optimal First-Line Therapy for Previously Untreated Chronic Lymphocytic Leukemia: The Case for Chemotherapy.
    Brown JR
    Oncology (Williston Park); 2015 Jun; 29(6):442, 444. PubMed ID: 26091679
    [No Abstract]   [Full Text] [Related]  

  • 6. Effective treatment of leukemia cutis with combination of rituximab, cladribine, and cyclophosphamide in patient with B-cell chronic lymphocytic leukemia.
    Batycka-Baran A; Baran W; Dzietczenia J; Mazur G
    Ann Hematol; 2011 Aug; 90(8):979-80. PubMed ID: 20978760
    [No Abstract]   [Full Text] [Related]  

  • 7. Richter syndrome in chronic lymphocytic leukaemia manifesting only as tumorous hepatomegaly.
    Tadmor T; Bejar J; Attias D; Polliack A
    Br J Haematol; 2011 Oct; 155(2):135. PubMed ID: 21973072
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemoimmunotherapy in chronic lymphocytic leukemia.
    Stilgenbauer S
    Clin Adv Hematol Oncol; 2010 Dec; 8(12):867-8. PubMed ID: 21326163
    [No Abstract]   [Full Text] [Related]  

  • 9. [Specific palatal infiltration in B-cell chronic lymphocytic leukemia].
    Cervigón I; Palomo A; Torres-Iglesias LM; Solano F; Zapata AM
    Actas Dermosifiliogr; 2011 May; 102(4):305-7. PubMed ID: 21354544
    [No Abstract]   [Full Text] [Related]  

  • 10. CHOP regimen versus intermittent chlorambucil-prednisone in stage B chronic lymphocytic leukemia. Short term results from a randomized clinical trial. French Cooperative Group on Chronic Lymphocytic Leukemia.
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):449-52. PubMed ID: 2906118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fludarabine as a second-line treatment of advanced stage chronic lymphocytic leukemia.
    Ayyildiz O; Isikdogan A; Bolaman Z; Muftuoglu E
    Saudi Med J; 2004 Dec; 25(12):2054-6. PubMed ID: 15711709
    [No Abstract]   [Full Text] [Related]  

  • 12. Peripheral blood CD38 expression predicts time to progression in B-cell chronic lymphocytic leukemia after first-line therapy with high-dose chlorambucil.
    Morabito F; Mangiola M; Stelitano C; Deaglio S; Callea V; Malavasi F
    Haematologica; 2002 Feb; 87(2):217-8. PubMed ID: 11836173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An "all-oral" combination therapy in chronic lymphocytic leukemia including the oral idarubicin.
    Molica S; Levato D; Di Renzo N; La Sala A; Carotenuto M
    Am J Hematol; 1996 Jul; 52(3):235-6. PubMed ID: 8756100
    [No Abstract]   [Full Text] [Related]  

  • 14. In defence of the use of modern chemotherapy regimens for the treatment of patients with chronic lymphocytic leukaemia.
    Tam CS
    Intern Med J; 2009 Dec; 39(12):858-9. PubMed ID: 20233254
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of subsequent therapies in patients with chronic lymphocytic leukemia previously treated with prednisone and either cladribine or chlorambucil.
    Robak T; Blonski JZ; Kasznicki M; Góra-Tybor J; Dmoszyñska A; Skotñicki A
    Haematologica; 2005 Jul; 90(7):994-6. PubMed ID: 15996945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab-containing therapy for chronic lymphocytic leukaemia.
    Tanimoto T; Sakiyama M; Hori A; Yagasaki F; Kami M
    Lancet; 2011 Jan; 377(9761):205; author reply 206. PubMed ID: 21237394
    [No Abstract]   [Full Text] [Related]  

  • 17. Rituximab-containing therapy for chronic lymphocytic leukaemia.
    Haines I; Elliott P; Stanley R
    Lancet; 2011 Jan; 377(9761):205; author reply 206. PubMed ID: 21237393
    [No Abstract]   [Full Text] [Related]  

  • 18. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia.
    Rai KR; Peterson BL; Appelbaum FR; Kolitz J; Elias L; Shepherd L; Hines J; Threatte GA; Larson RA; Cheson BD; Schiffer CA
    N Engl J Med; 2000 Dec; 343(24):1750-7. PubMed ID: 11114313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Auer rod-like inclusions in a low-grade B-cell leukemia.
    Hristov AC; Saladino A; Nava VE; Gocke CD
    Ann Diagn Pathol; 2010 Aug; 14(4):292-5. PubMed ID: 20637437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Coexistence of chronic lymphoid leukemia and Hodgkin's disease. Immunohistochemical study].
    Pérez del Río MJ; Fresno MF; Ramírez A; Veiga M; González M; Herrero A
    Sangre (Barc); 1996 Dec; 41(6):469-71. PubMed ID: 9148425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.